H. Roberts

发表

PROTHROMBIN-COMPLEX CONCENTRATES IN LIVER DISEASE

P. Mannucci, P. Blatt, N. Dioguardi, 1975, The Lancet.

ANTITHROMBIN-III TRANSFUSION IN DISSEMINATED INTRAVASCULAR COAGULATION

P. Blatt, J. Goldsmith, G. White, 1978, The Lancet.

THE PREVENTION OF HEMORRHAGE WITH ANTICOAGULANTS — AN EXPLORATORY STUDY OF A PARADOX *

H. Roberts, K. Brinkhous, W. P. Webster, 1964, Annals of the New York Academy of Sciences.

Extravascular Administration of Factor IX: Potential for Replacement Therapy of Canine and Human Hemophilia B

C. Lindley, D. Monroe, D. Liles, 1997, Thrombosis and Haemostasis.

Factor VIII Replacement Therapy

H. Roberts, 1991 .

Active Site-inactivated Factors VIIa, Xa, and IXa Inhibit Individual Steps in a Cell-based Model of Tissue Factor-initiated Coagulation

J. Oliver, D. Monroe, M. Ezban, 1998, Thrombosis and Haemostasis.

The Effect of Active Site-inhibited Factor VIIa on Tissue Factor-initiated Coagulation Using Platelets before and after Aspirin Administration

J. Oliver, D. Monroe, H. Roberts, 1997, Thrombosis and Haemostasis.

Coagulation Factor IXa Binding to Activated Platelets and Platelet-Derived Microparticles: A Flow Cytometric Study

D. Monroe, H. Roberts, M. Hoffman, 1992, Thrombosis and Haemostasis.

Detection of an Abnormal Plasma Clot Structure by a Simple Rigidity Assay

M. Carr, P. Blatt, J. Hermans, 1979, Thrombosis and Haemostasis.

Antithrombin III in Fresh Frozen Plasma, Cryoprecipitate, and Cryoprecipitate‐depleted Plasma

P. Mintz, W. Kuhns, P. Blatt, 1979, Transfusion.

Warfarin and Heparin-Induced Skin Necrosis and the Purple Toe Syndrome: Infrequent Complications of Anticoagulant Treatment

H. Roberts, D. Thomas, S. Sallah, 1997, Thrombosis and Haemostasis.

Comparison of PT, aPTT, and Factor VII Values Obtained by Concurrent Sample Collection by Direct Venipuncture and Peripheral Venous Catheters

C. Lindley, W. Sawyer, H. Roberts, 1994, Pharmacotherapy.

Molecular Biology of Hemophilia B

H. Roberts, H. Roberts, 1993, Thrombosis and Haemostasis.

The Factor VII-Platelet Interplay: Effectiveness of Recombinant Factor VIIa in the Treatment of Bleeding in Severe Thrombocytopathia

D. Monroe, H. Roberts, M. Hoffman, 2000, Seminars in thrombosis and hemostasis.

Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.

D. Monroe, H. Roberts, D. Stafford, 1997, The Journal of clinical investigation.

Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?

C. Kempton, B. Nielsen, H. Roberts, 2005, Journal of thrombosis and haemostasis : JTH.

A randomized, double‐blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors

Shapiro, Kasper, Y. Laurian, 1998 .

Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system

J. Oliver, A. Wolberg, D. Monroe, 2004, Journal of thrombosis and haemostasis : JTH.

Fibrinogen chapel hill: Hypodysfibrinogenemia with a tertiary polymerization defect

J. Mcdonagh, H. Roberts, H. Roberts, 1980, American journal of hematology.

A Survey of the Effectiveness of Prothrombin Complex Concentrates in Controlling Hemorrhage in Patients with Hemophilia and Anti-Factor VIII Antibodies

H. Roberts, D. Ménaché, P. Blatt, 1980, Thrombosis and Haemostasis.

Hemolysis caused by factor VIII concentrates.

M. Koury, E. Orringer, H. Roberts, 1976, Archives of internal medicine.

Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets

D. Gabriel, D. Monroe, H. Roberts, 2004, Journal of thrombosis and haemostasis : JTH.

A rapid method to isolate platelets from human blood by density gradient centrifugation.

D. Monroe, H. Roberts, M. Hoffman, 1992, American journal of clinical pathology.

Transmission of a procoagulant signal from tissue factor‐bearing cells to platelets

D. Monroe, H. Roberts, M. Hoffman, 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

A possible mechanism of action of activated factor VII independent of tissue factor.

J. Oliver, D. Monroe, H. Roberts, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Mechanism by which recombinant factor VIIa shortens the aPTT: activation of factor X in the absence of tissue factor.

D. Monroe, H. Roberts, B. G. Macik, 1989, Thrombosis research.

Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.

H. Roberts, H R Roberts, M Hoffman, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor.

K. High, M. Blajchman, D. Monroe, 1994, Blood.

Clinical experience with activated factor VII: focus on safety aspects.

H. Roberts, H. Roberts, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Cellular interactions in hemostasis.

D. Monroe, H. Roberts, M. Hoffman, 1996, Haemostasis.

Characterization of a Variant Prothrombin in a Patient Congenitally Deficient in Factors II, VII, IX and X

H. Roberts, K. McGrath, Ks Chung, 1980, British journal of haematology.

Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms.

A. Wolberg, D. Monroe, H. Roberts, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Prothrombin complex concentrates: potentially thrombogenic materials and clues to the mechanism of thrombosis in vivo.

H. Kingdon, G. White, H. Roberts, 1977, Blood.